Quest Diagnostics (DGX) SVP logs option, RSU grants and tax share disposals
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Quest Diagnostics SVP and Chief Accounting Officer Michael J. Deppe reported a mix of equity grants and related tax share withholdings. On February 18, 2026, he was granted a non‑qualified stock option covering 1,688 shares, which vests in three equal annual installments beginning on the first anniversary of the grant date.
He also received an award of 366 restricted stock units. To cover tax withholding from vesting RSUs, 83 shares of common stock at $210.01 and 99 shares at $206.99 were disposed of to the issuer. After these transactions, he directly owns 34,560 shares of common stock and holds 1,688 options, plus an additional 706 shares indirectly through the company’s 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Deppe Michael J
Role
SVP, Corp. Controller & CAO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualifed Stock Option (right to buy) | 1,688 | $0.00 | -- |
| Grant/Award | Common Stock | 366 | $0.00 | -- |
| Tax Withholding | Common Stock | 83 | $210.01 | $17K |
| Tax Withholding | Common Stock | 99 | $206.99 | $20K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualifed Stock Option (right to buy) — 1,688 shares (Direct);
Common Stock — 34,742 shares (Direct);
Common Stock — 706 shares (Indirect, 401(k))
Footnotes (1)
- Represents an award of restricted stock units. Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
FAQ
What insider transactions did Quest Diagnostics (DGX) report for Michael J. Deppe?
Michael J. Deppe reported receiving 1,688 non-qualified stock options and 366 restricted stock units, plus tax-related dispositions of 83 and 99 common shares. These transactions reflect equity compensation grants and associated share withholdings for tax obligations on vested restricted stock units.
How many Quest Diagnostics (DGX) stock options were granted to Michael J. Deppe?
Michael J. Deppe was granted non-qualified stock options covering 1,688 shares of Quest Diagnostics common stock. These options vest in three equal annual installments, beginning on the first anniversary of the grant date, aligning his long-term compensation with company performance and shareholder value.
What restricted stock unit (RSU) awards did Michael J. Deppe receive from Quest Diagnostics (DGX)?
He received an award of 366 restricted stock units in Quest Diagnostics common stock. A related footnote clarifies this as an RSU grant, which typically converts into shares upon vesting, forming part of his equity-based compensation package as a senior executive officer.
How are Michael J. Deppe’s 401(k) holdings in Quest Diagnostics (DGX) stock reported?
The Form 4 reports 706 shares of Quest Diagnostics common stock held indirectly through the company’s 401(k) plan. A footnote explains these shares are acquired periodically by the plan trustee, with share amounts based on account balances and prevailing market prices.